miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1

Solmaz Shirjang ¹ , Behzad Mansoori ^1,2,3, Ali Mohammadi ¹, Neda Shajari ⁴, Pascal H.G. Duijf ⁵, Souzan Najafi ¹, Fereydoon Abedi Gaballu ¹, Katayoon Nofouzi ⁶, Behzad Baradaran ¹ *

Cited by CrossRef: 13

1- Mazloum-Ravasan S, Mohammadi M, Hiagh E, Ebrahimi A, Hong J, Hamishehkar H, Kim K. Nano-liposomal zein hydrolysate for improved apoptotic activity and therapeutic index in lung cancer treatment. Drug Delivery. 2022;29(1):1049 [Crossref]

2- Beylerli O, Encarnacion Ramirez M, Shumadalova A, Ilyasova T, Zemlyanskiy M, Beilerli A, Montemurro N. Cell-Free miRNAs as Non-Invasive Biomarkers in Brain Tumors. Diagnostics. 2023;13(18):2888 [Crossref]

3- Padilla J, Lee J. A Novel Therapeutic Target, BACH1, Regulates Cancer Metabolism. Cells. 2021;10(3):634 [Crossref]

4- Jiang P, Li F, Liu Z, Hao S, Gao J, Li S. BTB and CNC homology 1 (Bach1) induces lung cancer stem cell phenotypes by stimulating CD44 expression. Respir Res. 2021;22(1) [Crossref]

5- Mustafov D, Siddiqui S, Klena L, Karteris E, Braoudaki M. SV2B/miR-34a/miR-128 axis as prognostic biomarker in glioblastoma multiforme. Sci Rep. 2024;14(1) [Crossref]

6- Tang M, Wang F, Wang K, Jiang Y, Wang Q. Circ_0058063 promotes progression of thyroid cancer by sponging miR-330-3p/SDC4 axis. 2022;33(7):642 [Crossref]

7- Cui J, Wang H, Liu S, Zhao Y. New Insights into Roles of IL-7R Gene as a Therapeutic Target Following Intracerebral Hemorrhage. JIR. 2024;Volume 17:399 [Crossref]

8- Karimi L, Jaberi M, Asadi M, Zarredar H, Zafari V, Bornehdeli S, Niknam S, Kermani T. Significance of microRNA-330-5p/TYMS Expression Axis in the Pathogenesis of Colorectal Tumorigenesis. J Gastrointest Canc. 2022;53(4):965 [Crossref]

9- Zhang Q, Wang S. miR‐330 alleviates dextran sodium sulfate‐induced ulcerative colitis through targeting IRAK1 in rats. The Kaohsiung J of Med Scie. 2021;37(6):497 [Crossref]

10- Ghafouri-Fard S, Hussen B, Badrlou E, Abak A, Taheri M. MicroRNAs as important contributors in the pathogenesis of colorectal cancer. Biomedicine & Pharmacotherapy. 2021;140:111759 [Crossref]

11- Huang B, Cui D, Yan F, Yang L, Zhang M, Zhao X. Circ_0087862 promotes the progression of colorectal cancer by sponging miR‐142‐3p and up‐regulating BACH1 expression. The Kaohsiung J of Med Scie. 2021;37(12):1048 [Crossref]

12- Shao Y, Yang Z, Miao W, Yu X, Pu Y. Circ_0005015 upregulates BACH1 to promote aggressive behaviors in glioblastoma by sponging microRNA-382-5p. Naunyn-Schmiedeberg's Arch Pharmacol. 2023; [Crossref]

13- Papale M, Netti G, Stallone G, Ranieri E. Understanding Mechanisms of RKIP Regulation to Improve the Development of New Diagnostic Tools. Cancers. 2022;14(20):5070 [Crossref]

14- Wang J, Han B, Zhao X, Sun Y, Liu Y, Hu F, Meng K. MicroRNA-532-5p upregulation protects neurological deficits after ischemic stroke through inhibition of BTB and CNC homology 1. International Immunopharmacology. 2021;100:108003 [Crossref]

15- Guo Q, Dong L, Zhang C, Liu D, Peng P. MicroRNA-363-3p, negatively regulated by long non-coding RNA small nucleolar RNA host gene 5, inhibits tumor progression by targeting Aurora kinase A in colorectal cancer. Bioengineered. 2022;13(3):5357 [Crossref]

16- Wang J, Ke S, Gong Y, Cai Y, Xia L, Shi Z, Qiu H, Shi W, Wang Q, Chen Y. Circ_0011385 knockdown inhibits cell proliferation, migration and invasion, whereas promotes cell apoptosis by regulating miR-330-3p/MYO6 axis in colorectal cancer. Biomedical Journal. 2023;46(1):110 [Crossref]

17- Jafarzadeh A, Paknahad M, Nemati M, Jafarzadeh S, Mahjoubin-Tehran M, Rajabi A, Shojaie L, Mirzaei H. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target. Biomedicine & Pharmacotherapy. 2022;146:112600 [Crossref]